Acelity, looking to accelerate its plans for a disposable negative-pressure wound therapy, said today that it acquired the Snap portable NPWT device from Spiracur for an undisclosed amount.
San Antonio, Texas-based Acelity, which is preparing for an initial public offering that could fetch up to $1 billion, said the Snap system is designed to treat hard-to-heal wounds with a portable, unpowered device.
“As an organization, we continually seek out opportunities to fulfill our vision of restoring people’s lives through advancements in wound care technology,” president & CEO Joe Woody said in prepared remarks. “The addition of the Snap system complements our existing suite of clinically-proven products that speed healing and reduce costs to health systems around the world. We will continue to develop and enhance our offerings through innovation and acquisitions to remain at the forefront of healing solutions.
“Looking ahead, we are well positioned to build upon our trusted and innovative portfolio of solutions to include near adjacencies such as easy-to-use dressings and other complementary products,” Woody added. “Working with clinicians across the continuum of care, we are expanding our focus to ensuring therapy compliance with technologies such as remote monitoring and telehealth elements that will leverage our deep knowledge and expertise.”
